Other reports

Economics

TAG overview

Net sales, operating result (EBIT) and research and development costs, by business sector1

€ million

 

Life Science

 

Healthcare

 

Electronics

 

Group

 

 

 

 

 

 

 

 

 

2022

Net sales

 

10,380

 

7,839

 

4,013

 

22,232

Operating result (EBIT)

 

2,808

 

1,895

 

572

 

4,474

R&D costs2

 

399

 

1,694

 

308

 

2,521

 

 

 

 

 

 

 

 

 

2023

Net sales

 

9,281

 

8,053

 

3,659

 

20,993

Operating result (EBIT)

 

1,850

 

2,225

 

248

 

3,609

R&D costs2

 

396

 

1,657

 

297

 

2,445

1

As a non-operating segment, Corporate and Other is not shown here as a separate item, but rather under Segment Reporting in our Annual Report 2023 (p. 252-256).

2

Not presented are research and development costs of € 94 million (2022: € 119 million) allocated to Corporate and Other.

Share this page: